The impacts on constitutively active BCR::ABL1 oncogenic signaling that results in unchecked proliferation and apoptosis inhibition in CML were examined using molecular docking and molecular dynamics simulations. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.